Humacyte, Inc. (HUMA) vs ProMIS Neurosciences, Inc. (PMN)
A side-by-side comparison of Humacyte, Inc. and ProMIS Neurosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HUMA
Humacyte, Inc.
$0.50HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
PMN
ProMIS Neurosciences, Inc.
$9.34HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — HUMA vs PMN
growth of $100 · dividends reinvested · last 6yHUMA -94.8% (-39.0%/yr)PMN -92.2% (-34.6%/yr)PMN compounded faster over this window
HUMA PMN
HUMA vs PMN: by the numbers
- •HUMA is the larger company ($84M vs $84M market cap).
- •Both run net losses; PMN's is the smaller (0.00% vs -4560.82% net margin).
Metrics side by side
Valuation
| Metric | HUMA | PMN |
|---|---|---|
| P/S ratio | 39.61 | N/A |
| P/B ratio | 2.69 | 1.70 |
Profitability
| Metric | HUMA | PMN |
|---|---|---|
| Gross margin | -736.46% | 0.00% |
| Operating margin | -5271.69% | 0.00% |
| Net margin | -4560.82% | 0.00% |
| ROE | -309.44% | -85.48% |
| ROIC | -90.27% | -87.79% |
Growth (annualized)
| Metric | HUMA | PMN |
|---|---|---|
| Revenue CAGR (5Y) | 2.41% | N/A |
| Total return CAGR (5Y) | -45.73% | -47.05% |
Frequently asked
- How have HUMA and PMN total returns compared?
- Over the past 5 years, HUMA delivered -45.73% and PMN delivered -47.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.